Results 1 to 10 of about 189,721 (246)

Immune-mediated polyarthritis in dogs: Are corticosteroids the best bet?

open access: yesVeterinary Evidence, 2023
PICO question In dogs with type I immune-mediated polyarthritis (IMPA), is sole treatment with other immunosuppressive agents as effective as treatment with corticosteroids at reducing clinical signs?
Hannah Walker
doaj   +1 more source

Transitional type of Castleman's disease manifested as the POEMS syndrome [PDF]

open access: yesVojnosanitetski Pregled, 2004
Background. Castleman’s disease is an atypical lymphoproliferative disorder characterized by angiofollicular hyperplasia of lymph nodes. Histologically it can be classified into a hyaline-vascular type, plasma-cell type, and transitional (mixed-cell ...
Tomić Ilija   +4 more
doaj   +1 more source

Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications

open access: yesFrontiers in Oncology, 2023
Background/objectiveWe retrospectively analyzed the effective and safety of continuous low-dose cyclophosphamide combined with prednisone (CP) in relapsed and refractory multiple myeloma (RRMM) patients with severe complications.MethodsA total of 130 ...
Haotian Shi   +9 more
doaj   +1 more source

The Clinical Effect of Steroids for Hearing Preservation in Cochlear Implantation: Conclusions Based on Three Cochlear Implant Systems and Two Administration Regimes

open access: yesPharmaceuticals, 2022
The main aim of this study was to assess the clinical effect of steroids (dexamethasone and prednisone) on hearing preservation in patients who underwent cochlear implantation with different cochlear implant systems (Oticon®, Advanced Bionics®, Med-El®).
Magdalena B. Skarżyńska   +7 more
doaj   +1 more source

Influence of Different Types of Corticosteroids on Heart Rate Variability of Individuals with Duchenne Muscular Dystrophy—A Pilot Cross Sectional Study

open access: yesLife, 2021
Individuals with Duchenne Muscular Dystrophy (DMD) have an impairment of cardiac autonomic function categorized by parasympathetic reduction and sympathetic predominance.
Rodrigo Martins Dias   +13 more
doaj   +1 more source

The Effects of Prednisone/Ketoprofen Administration in Association with Amoxicillin Clavulanate Following Periodontal Surgical Therapy in Patients with Severe Chronic Periodontitis

open access: yesMedicina, 2021
Background and Objectives: The aim of this study was to evaluate and compare the effects of two different anti-inflammatory drugs (ketoprofen and prednisone) combined with an antibiotic (amoxicillin + clavulanic acid) and periodontal surgery on dental ...
Lidia Sfetcu   +7 more
doaj   +1 more source

Early use of corticosteroids in non-critical patients with COVID-19 pneumonia (PREDCOVID): a structured summary of a study protocol for a randomised controlled trial

open access: yesTrials, 2021
Objectives To evaluate the efficacy of early treatment with prednisone to decrease the progression of COVID-19 pneumonia. Trial design This is a pragmatic, non-blinded, randomized, two arms, parallel trial.
Mauricio Salinas   +5 more
doaj   +1 more source

Enhancing Prednisone-Based Arthritis Therapy with Targeted IL-27 Gene Delivery

open access: yesBioengineering, 2022
Rheumatoid arthritis (RA) is a chronic autoimmune disease which is characterized primarily by synovial hyperplasia and accumulation of several types of immune infiltrates that promote progressive destruction of the articular structure.
Adriana A. Marin   +6 more
doaj   +1 more source

Diagnostic Ideas and Management Strategies for Thrombocytopenia of Unknown Causes in Pregnancy

open access: yesFrontiers in Surgery, 2022
ObjectiveTo summarize the clinical characteristics and treatment options together with the maternal and neonatal prognoses in women with different degrees of thrombocytopenia of unknown causes during pregnancy.Materials and MethodsOne hundred twenty-nine
Jie Li   +5 more
doaj   +1 more source

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

open access: yeseJHaem, 2023
This phase Ib, non‐randomized, open‐label study evaluates the safety and tolerability of ruxolitinib in combination with nilotinib and prednisone in patients with naïve or ruxolitinib‐resistant myelofibrosis (MF).
Rosa Ayala   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy